Emily English
Algemeen Directeur bij Gemstone Biotherapeutics LLC
Vermogen: - $ op 30-04-2024
Profiel
Emily P.
English is currently the Chief Executive Officer at Gemstone Biotherapeutics LLC and the Vice President-Quality Assurance at Cartesian Therapeutics, Inc. She previously worked as the Chief Executive Officer at The Johns Hopkins University.
Dr. English holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Maryland.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
-.--% | 18-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Emily English
Bedrijven | Functie | Begin |
---|---|---|
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Algemeen Directeur | - |
Eerdere bekende functies van Emily English
Bedrijven | Functie | Einde |
---|---|---|
The Johns Hopkins University | Algemeen Directeur | - |
Opleiding van Emily English
University of Maryland | Undergraduate Degree |
University of Wisconsin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Health Technology |